Heart Test Laboratories, Inc., a medical technology company, provides cardiovascular diagnostic devices. The company offers MyoVista wavECG, a resting 12-lead electrocardiograph (ECG) to provide diagnostic information related to cardiac dysfunction, as well as conventional 12-lead resting ECG information. It serves clinics, doctor's offices, urgent care centers, and hospitals. The company was incorporated in 2007 and is headquartered in Southlake, Texas.

Company Data

Name Heart Test Laboratories, Inc. - Common Stock

Company Heart Test Laboratories, Inc.

Symbol HSCS

Website https://heartsciences.com

Primary Exchange

NASDAQ

ISIN US42254E1047

Asset Class Share

Sector Healthcare

Industry Medical - Devices

CEO Andrew Simpson

Country United States of America

Currency USD

Employees 0,0 T

Address 550 Reserve Street, 76092-1552 Southlake

IPO Date 2022-06-16

Ticker Symbols

Name	Symbol
NASDAQ	HSCS

More Shares

Investors who hold Heart Test Laboratories, Inc. - Common Stock also have the following shares in their portfolio:

NITTAN Corporation Share

Rongfeng Holding Group Co.,Ltd. Share

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog